AGN Media thread, page-185

I have 100 percent certainty that AGN will pass safety with flying colours and pre clinical studies over the next 6 months. The same peptides in the same class have already confirmed this type of peptides safety.

But to say this drug works in humans when many drugs in the same class as this drug have not gotten any human response in previous phase 2 and 3 trials means AGN will highly likely fail. AGN is not a new class of drug, this type of peptide has been trialed many times before. But in it for the short term run into safety and pre clinical success